Abstract:Abstract Background Colorectal cancer is the second leading cause of cancer death in Canada. A major risk factor for the development of colorectal cancer is chronic inflammation leading to colitis-associated cancer (CAC). We previously described a CAC mouse model in which tumors arise from DCLK1+ tuft cells following loss of the tumor suppressor adenomatous polyposis coli (APC) and induction of colitis. Interestingly, both colitis and CAC display epigenetic changes that modulate gene expression. However, the impact of DNA methylation changes on colonic tumorigenesis is not known. Thus, we hypothesize that inhibition of DNA methylation in DCLK1+ tuft cells reduces colonic tumorigenesis. Purpose In this study, we aim to investigate the role of DNA methylation in CAC by inhibiting DNA methylation using genetic and pharmacologic means. Method Using a publicly available dataset (GSE75214) of gene expression data analyzed by microarray from colonic biopsies of patients with ulcerative colitis and Crohn’s Disease with active disease, we examined the expression of DNA methyltransferases (DNMTs). Expression of DNMTs in mice with colitis was additionally examined by RT-qPCR and global DNA methylation levels measured by 5-mC ELISA. In separate experiments, Dclk1-CreERT2/Apcf/f mice were crossed to DNMT1f/f mice to knock-out the DNA methyltransferase DNMT1 in DCLK1+ tuft cells. Dclk1/Apcf/f and Dclk1/Apcf/f/DNMT1f/f mice were then administered three doses of tamoxifen followed by 2.5% dextran sodium sulfate (DSS) for five days to induce colitis. Fourteen weeks later, we assessed colonic tumor number and size. In a separate cohort of Dclk1/Apcf/f mice, we induced colitis and treated the mice with six doses of the DNA de-methylating drug 5-AZA-2’-deoxycytidine (5-AZA) or vehicle, and assessed colonic tumor number. To examine DNA methylation changes, we then treated WT mice with 5-AZA and DSS and isolated intestinal epithelial cells. From the intestinal epithelial cell, we isolated DNA and ran the Infinium MouseMethylation BeadChip Array. Result(s) Patients with IBD were found to have increased expression of DNMT1 compared to healthy controls. Mice treated with DSS similarly had increased DNMT1 expression, as well as, global methylation levels compared to controls. Deletion of DNMT1 in DCLK1+ cells significantly inhibited the number and size of colonic tumors. Treatment of mice with 5-AZA decreased global and gene specific DNA methylation levels, and significantly reduced both the number of mice with tumors, and the average colonic tumor number and size per mouse. Conclusion(s) Our findings demonstrate that colitis in both patients and mice is associated with DNA methylation. Furthermore, DNA hypomethylation by 5-AZA treatment or loss of DNMT1 reduces CAC formation suggesting that altered DNA methylation plays a critical role in colonic tumorigenesis. Disclosure of Interest None Declared

Epigenetic Modification Regulates Both Expression of Tumor-Associated Genes and Cell Cycle Progressing in Human Colon Cancer Cell Lines: Colo-320 and SW1116.

The effects of 5-Aza-2-deoxycytidine, a methylation inhibitor, on the proliferation of androgen-sensitive prostate cancer cell line, and on the regulation of methylation of glutathione s-transferase P1 and retinoic acid receptorβ2 gene

Epigenetics Are Involved in the Regulation of the Cell Cycle and Expression of Tumor Suppressor Genes in Human Colon Cancer Cells

[Regulation of Histone Acetylation on the Expression of Cell Cycle-Associated Genes in Human Colon Cancer Cell Lines].

Effects of Dna Methylation on Expression of Tumor Suppressor Genes and Proto-Oncogene in Human Colon Cancer Cell Lines

Regulation of DNA Methylation on Expression of Genes in Human Gastric Cancer Cell Lines

A35 DNA HYPOMETHYLATION INHIBITS TUFT CELL-DERIVED COLITIS-ASSOCIATED CANCER

[The Study of 5-Aza-2'-deoxycytidine on Transcription Regulation of P16/cdkn2 Gene Demethylation in RKO Human Colorectal Cell Line].

A27 DNA HYPOMETHYLATION INDUCED BY 5-AZA-CDR OR LOSS OF DNMT1 INHIBITS COLITIS-ASSOCIATED COLORECTAL CANCER

5-Aza-2 '-Deoxycitydine Induces Demethylation and Up-Regulates Transcription of P16(Ink4a) Gene in Human Gastric Cancer Cell Lines

Histone Acetylation Regulates P21waf1 Expression in Human Colon Cancer Cell Lines.

Histone Acetylation Regulates P21^waf1 Expression in Human Colon Cancer Cell Lines

Inhibition of the Extracellular Signal-Regulated Kinase/mitogen-Activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells.

Effects of Epigenetic Drugs on BRCA1 and CHD5 Expressions in Breast Cancer Cells

Effects of 5-Aza-2'-deoxycytidine on Biological Behavior of Colon Tumor Cell Lines

Effects of 5-Aza-dcr and TSA on Methylation of Transcription Regulation of Syk Gene in Colorectal Cancer Cell Line

The Expression of Tumor-associated Genes and Methylation in Human Gastric Cancer Cells

Regulation of multiple genes by DNA methylation and folate intervention in human gastric cancer cell lines

Inhibition of DNMT Suppresses the Stemness of Colorectal Cancer Cells Through Down-Regulating Wnt Signaling Pathway.

Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1

Temporal DNA Methylation Pattern and Targeted Therapy in Colitis-Associated Cancer